Home/Filings/4/0001437749-14-003442
4//SEC Filing

Oxford Immunotec Global PLC 4

Accession 0001437749-14-003442

CIK 0001586049operating

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 10:56 AM ET

Size

6.7 KB

Accession

0001437749-14-003442

Insider Transaction Report

Form 4
Period: 2014-03-03
Altieri Richard M.
Chief Financial Officer
Transactions
  • Award

    Ordinary Shares

    2014-03-03+28,72028,720 total
  • Award

    SHARE OPTION (RIGHT TO BUY)

    2014-03-03+28,72028,720 total
    Exercise: $22.99Exp: 2024-03-03Ordinary Shares (28,720 underlying)
Footnotes (2)
  • [F1]Option granted under Issuer's 2013 Share Incentive Plan.
  • [F2]Will become exercisable as to 1,795 shares on April 1, 2014 and will become exercisable as to the remainder ratably on the first day of each month from May 1, 2014 through January 1, 2018.

Issuer

Oxford Immunotec Global PLC

CIK 0001586049

Entity typeoperating
IncorporatedUnited Kingdom

Related Parties

1
  • filerCIK 0001586049

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 10:56 AM ET
Size
6.7 KB